Advanced Progress of Histone Deacetylases in Rheumatic Diseases

被引:2
|
作者
Liu, Xue-Mei [1 ,2 ]
Yang, Liu [1 ,2 ]
Yang, Qi-Bin [1 ,3 ]
机构
[1] North Sichuan Med Coll, Affiliated Hosp, Dept Rheumatol & Immunol, Nanchong 637000, Sichuan, Peoples R China
[2] Sichuan Med Coll, Grad Sch North, Dept Clin Med, Nanchong 637000, Sichuan, Peoples R China
[3] North Sichuan Med Coll, Affiliated Hosp, Dept Rheumatol & Immunol, 1 Maoyuannan Rd, Nanchong 637000, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
histone deacetylase; histone deacetylase inhibitor; rheumatic diseases; IDIOPATHIC PULMONARY-FIBROSIS; BLOOD MONONUCLEAR-CELLS; KAPPA-B; ANKYLOSING-SPONDYLITIS; GENE-EXPRESSION; SYSTEMIC-SCLEROSIS; LUNG-DISEASE; MOUSE MODEL; ARTHRITIS; SIRT1;
D O I
10.2147/JIR.S447811
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rheumatic disease is a disease which is not yet fully clarified to etiology and also involved in a local pathological injury or systemic disease. With the continuous improvement of clinical medical research in recent years, the development process of rheumatic diseases has been gradually elucidated; with the intensely study of epigenetics, it is realized that environmental changes can affect genetics, among which histone acetylation is one of the essential mechanisms in epigenetics. Histone deacetylases (HDACs) play an important role in regulating gene expression in various biological processes, including differentiation, development, stress response, and injury. HDACs are involved in a variety of physiological processes and are promising drug targets in various pathological conditions, such as cancer, cardiac and neurodegenerative diseases, inflammation, metabolic and immune disorders, and viral and parasitic infections. In this paper, we reviewed the roles of HDACs in rheumatic diseases in terms of their classification and function.
引用
收藏
页码:947 / 955
页数:9
相关论文
共 50 条
  • [1] Histone Deacetylases and Cardiometabolic Diseases
    Yiew, Kan Hui
    Chatterjee, Tapan K.
    Hui, David Y.
    Weintraub, Neal L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (09) : 1914 - 1919
  • [2] Dysregulation of histone deacetylases in ocular diseases
    Jae Hyun Jun
    Jun-Sik Kim
    Leon F. Palomera
    Dong-Gyu Jo
    Archives of Pharmacal Research, 2024, 47 (1) : 20 - 39
  • [3] Targeting histone deacetylases for heart diseases
    Jin, Gang
    Wang, Kaiyue
    Zhao, Yaohui
    Yuan, Shuo
    He, Zhangxu
    Zhang, Jingyu
    BIOORGANIC CHEMISTRY, 2023, 138
  • [4] Histone Deacetylases as Targets for Multiple Diseases
    Sangshetti, Jaiprakash N.
    Sakle, Nikhil S.
    Dehghan, M. H. G.
    Shinde, Devanand B.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 1005 - 1026
  • [5] Dysregulation of histone deacetylases in ocular diseases
    Jun, Jae Hyun
    Kim, Jun-Sik
    Palomera, Leon F.
    Jo, Dong-Gyu
    ARCHIVES OF PHARMACAL RESEARCH, 2024, 47 (01) : 20 - 39
  • [6] Histone deacetylases in cardiovascular and metabolic diseases
    Bagchi, Rushita A.
    Weeks, Kate L.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 130 : 151 - 159
  • [7] Histone deacetylases and their inhibitors in inflammatory diseases
    Zhang, Sen-Yu
    Zhang, Li-Ying
    Wen, Ri
    Yang, Ni
    Zhang, Tie-Ning
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [8] Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases
    Glauben, Rainer
    Siegmund, Britta
    MOLECULAR MEDICINE, 2011, 17 (5-6) : 426 - 433
  • [9] Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases
    Sharma, Sorabh
    Sarathlal, K. C.
    Taliyan, Rajeev
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019, 18 (01) : 11 - 18
  • [10] Histone deacetylases as targets in autoimmune and autoinflammatory diseases
    Hamminger, Patricia
    Rica, Ramona
    Ellmeier, Wilfried
    ADVANCES IN IMMUNOLOGY, VOL 147, 2020, 147 : 1 - 59